495 Aim: To assess available literature on FDG-PET/CT and contrast-enhanced CT in
response evaluation in metastatic breast cancer (MBC) by PET Response Criteria in Solid …

18F-fluorodeoxyglucose positron emission tomography with integrated computed
tomography (FDG-PET/CT) and contrast-enhanced computed tomography (CT) can be used …

Purpose The aim of this study was to compare fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT) and contrast-enhanced computed …

Breast cancer prognosis is steadily improving due to early detection of primary cancer in
screening programs and revolutionizing treatment development. In the metastatic setting …

494 Aim: We aimed to retrospectively examine the applicability of the PET Response Criteria
in Solid Tumors (PERCIST) when using FDG-PET/CT for response monitoring in patients …

Background This study aimed to compare contrast-enhanced CT (CE-CT) and FDG-PET/CT
for response monitoring in metastatic breast cancer (MBC) using the standardized response …

This study aimed to compare contrast-enhanced CT (CE-CT) and 18F-FDG PET/CT for
response monitoring in metastatic breast cancer using the standardized response …

1370 Aim: The purpose was to investigate FDG-PET/CT for response monitoring compared
to contrast-enhanced computerized tomography (CE-CT) in patients with metastatic breast …

This study aimed to compare CE-CT and 2-[18F] FDG-PET/CT for response monitoring
metastatic breast cancer (MBC). The primary objective was to predict progression-free and …

While current international guidelines include imaging of the target lesion for response
monitoring in metastatic breast cancer, they do not provide specific recommendations for …